2-[4-(2,2-Dimethylpropanoyl)piperazin-1-yl]ethanol hydrochloride, 95.0%, 250mg

1-Methyl-1H-indazol-5-ol, 95.0%, 250mg

Plan PLPHi 20x/0.40 phase contrast IOS infinity corrected objective

3-(4-Chloro-phenyl)-3-oxo-propionic acid methylester, 95.0%, 1g

2-(1-(4-Chlorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

Ethyl 4,6-dichloroquinoline-3-carboxylate, 95.0%, 1g

3-(3,4-DIMETHOXYPHENYL)PROPANENITRILE, 97.0%, 250mg

2-Bromo-3-methylquinoxaline, 98+%, 250mg

METHYL 5-FORMYL-3-(TRIFLUOROMETHYL)THIOPHENE-2-CARBOXYLATE, 95.0%, 250mg

4-Methylbenzyl methyl sulfide, 97.0%, 1g

(4S,5R)-3-(tert-Butoxycarbonyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 98%, 10g

5-Bromo-N-isopropyl-2-nitroaniline, 95+%, 5g

N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-nitrobenzamide, 96%, 5g